Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy	Nerve Degeneration, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies, spinal cord disorder	Recruiting	Not stated	2025-12-08		NCT07268833

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda Ospedaliero Universitaria di Cagliari	3
Federico II University	73
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	55
IRCCS San Raffaele	223

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Azienda Ospedaliera Universitaria Federico II	Naples	Italy	33
Azienda Ospedaliero Universitaria di Cagliari	Monserrato	Italy	1
Fondazione IRCCS Istituto Neurologico Carlo Besta	Milan	Italy	16
IRCCS Ospedale San Raffaele SRL	Milan	Italy	1